Clinical trials
Completed Phase 2 Muscular Atrophy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2017 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Baylor College of Medicine | 1 |
| Chang Gung Memorial Hospital | 1 |
| Eli Lilly and Company | 1 |
| GTx | 1 |
| German Cancer Research Center | 1 |
| Hill-Rom | 1 |
| Scholar Rock, Inc. | 1 |
| Stinus Gadegaard Hansen | 1 |
| Tufts University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscular Atrophy | 20 |
| Sarcopenia | 3 |
| Atrophy | 2 |
| Cachexia | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Muscle Weakness | 2 |
| Anterior Cruciate Ligament Injuries | 1 |
| Bone Diseases, Metabolic | 1 |
| COVID-19 | 1 |
| Carcinoma, Bronchogenic | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.